CPIX - Cumberland Pharmaceuticals Inc.
IEX Last Trade
1.385
0.025 1.805%
Share volume: 3,606
Last Updated: Fri 30 Aug 2024 09:58:53 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$1.36
0.03
1.84%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
| Report Date | 2022-05-13 | 2022-08-12 | 2022-11-14 | 2023-03-13 | 2023-05-12 | 2023-08-11 | 2023-11-13 | 2024-03-13 | |
| Assets | |||||||||
| Total Assets | 96.697 M | 92.518 M | 90.777 M | 92.925 M | 89.469 M | 89.375 M | 87.751 M | 81.776 M | |
| Current Assets | 45.342 M | 43.748 M | 49.161 M | 45.870 M | 43.811 M | 43.674 M | 41.770 M | 35.714 M | |
| Inventories | 9.879 M | 9.420 M | 10.648 M | 9.864 M | 10.180 M | 10.928 M | 8.671 M | 4.609 M | |
| Other Current Assets | 3.561 M | 2.835 M | 3.739 M | 3.085 M | 2.715 M | 2.278 M | 1.971 M | 3.025 M | |
| Short Term Investments | 3.561 M | 2.835 M | 3.739 M | 3.085 M | 2.715 M | 2.278 M | 1.971 M | 3.025 M | |
| Total Receivables | 14.635 M | 13.276 M | 15.233 M | 13.164 M | 14.529 M | 12.219 M | 12.620 M | 9.758 M | |
| Current Cash | 17.267 M | 18.217 M | 19.542 M | 19.758 M | 16.386 M | 18.249 M | 18.508 M | 18.322 M | |
| Total Non-current Assets | 51.355 M | 48.769 M | 41.616 M | 47.055 M | 45.658 M | 45.701 M | 45.981 M | 46.062 M | |
| Property Plant Equipment | 409.121 K | 457.490 K | 490.826 K | 284.039 K | 354.857 K | 384.383 K | 377.439 K | 367.903 K | |
| Other Assets | 13.773 M | 12.911 M | 9.924 M | 10.048 M | 10.080 M | 9.302 M | 10.857 M | 15.497 M | |
| Intangible Assets | 34.479 M | 32.975 M | 29.048 M | 30.591 M | 29.390 M | 28.270 M | 27.121 M | 22.608 M | |
| Goodwill | 1.933 M | 1.933 M | 1.933 M | 914.000 K | 914.000 K | 914.000 K | 914.000 K | 914.000 K | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 96.697 M | 92.518 M | 90.777 M | 92.925 M | 89.469 M | 89.375 M | 87.751 M | 81.776 M | |
| Total liabilities | 55.674 M | 53.055 M | 52.012 M | 56.659 M | 53.108 M | 52.216 M | 51.759 M | 52.173 M | |
| Total current liabilities | 24.557 M | 24.252 M | 25.306 M | 28.580 M | 25.707 M | 26.959 M | 27.328 M | 27.982 M | |
| Accounts Payable | 11.448 M | 10.592 M | 11.511 M | 10.819 M | 11.222 M | 10.912 M | 10.818 M | 14.038 M | |
| Other liabilities | 11.324 M | 10.061 M | 9.279 M | 5.063 M | 7.091 M | 6.954 M | 6.455 M | 3.559 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 20.000 M | 19.000 M | 17.700 M | 16.200 M | 16.072 M | 13.148 M | 12.923 M | 12.784 M | |
| Other liabilities | 11.324 M | 10.061 M | 9.279 M | 5.063 M | 7.091 M | 6.954 M | 6.455 M | 3.559 M | |
| Minority interest | -229.508 K | -258.554 K | -273.141 K | -292.126 K | -312.024 K | -322.070 K | -335.991 K | -343.572 K | |
| Total Shareholder equity | 41.023 M | 39.463 M | 38.764 M | 36.266 M | 36.361 M | 37.159 M | 35.992 M | 29.603 M | |
| Common stock | 14.692 M | 14.689 M | 14.477 M | 14.397 M | 19.758 M | 14.394 M | 14.277 M | 8.766 M | |
| Retained earnings | -7.024 M | -8.359 M | -8.768 M | -11.209 M | -11.017 M | -10.144 M | -11.194 M | -17.488 M |